Controlled release of growth factors for regenerative medicine

Current Pharmaceutical Design

Volumn 21, Issue 12, 2015, Pages 1627-1632

  Liu, Libiao ^a   Zhou, Xinwei ^a   Xu, Yufan ^a   Zhang, Weiming ^a   Liu, Cheng Hsien ^b   Wang, Xiaohong ^a,c  

^a TSINGHUA UNIVERSITY   (China)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Controlled release; Growth factors (GFs); Microencapsulation techniques; Regenerative medicine; Stem cells

Indexed keywords

BIOMATERIAL; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; MICROSPHERE; NANOPARTICLE; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; POLYGLACTIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT SOMATOMEDIN C; VASCULOTROPIN; DELAYED RELEASE FORMULATION; SIGNAL PEPTIDE;

ANGIOGENESIS; ARTICLE; BONE REGENERATION; CARTILAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; EXTRACELLULAR MATRIX; HEART MUSCLE; HUMAN; LIVER REGENERATION; MICROENCAPSULATION; NANOENCAPSULATION; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL; TISSUE REGENERATION; ANIMAL; CHEMISTRY; CYTOLOGY; DELAYED RELEASE FORMULATION; PHYSIOLOGY; PROCEDURES;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; REGENERATIVE MEDICINE; STEM CELLS;

EID: 84930891405     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666150115154602     Document Type: Article

References (80)

1. He XS, Zhou J, Ju WQ. The situation of organ transplant in the ear of organ donation. Theory and Practice of Surgery 2014; 19: 281-4.
2. Barthes J, Ozcelik H, Hindie M, et al. Cell microenvironment engineering and monitoring for tissue engineering and regenerative medicine: the recent advances. Biomed Res Int 2014; 10: 905-21.
3. Lebkowski JS, Gold J, Xu C, et al. Human embryonic stem cells: culture, differentiation, and genetic modification for regenerative medicine applications. Cancer J 2000; 7: S83-93.
4. Xu Y, Shi Y, Ding S. A chemical approach to stem-cell biology and regenerative medicine. Nature 2008; 453(7193): 338-44.
5. Björklund LM, Sánchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 2002, 99(4): 2344-9.
6. Caspi O, Lesman A, Basevitch Y, et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 2007; 100(2): 263-72.
7. Mimeault M, Hauke R, Batra SK. Stem cells: a revolution in therapeutics— recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 2007; 82(3): 252-64.
8. Richards M, Fong CY, Chan WK, et al. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nature Biotechnol 2002; 20(9): 933-6.
9. Amit M, Shariki C, Margulets V, et al. Feeder layer-and serum-free culture of human embryonic stem cells. Biol Reprod 2004; 70(3): 837-45.
10. Körbling M, Estrov Z. Adult stem cells for tissue repair-a new therapeutic concept. N Engl J Med 2003; 349(6): 570-82.
11. Franz WM, Zaruba M, Theiss H, David R. Stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. The Lancet 2003; 362: 675-6.
12. Jackson KA, Majka SM, Wang HY, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001; 107: 1395–402.
13. Liao C. Incorporration of chitosan microspherer into chitosanpolycaprolactone scaffolds for controlled release of transforming growth factor-_1. Wuhan: Huazhong University of science and technology. 2013.
14. Sha H. Development of controlled release vehicle and related survey of construction of functional tissue engineering skin equivalent. Xiàn: Fourth military medical University. 2008.
15. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnology 2001; 19: 10-29.
16. Bai J, Yang J, Zhu DW. Growth factors and their Multiple interactions in vivo microenvironment. CN Sci Bull 2006; 51: 506-13.
17. Shah NJ, Macdonald ML, Beben YM, et al. Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials 2011; 32: 61-83.
18. Lee K, Silva EA, Mooney DJ. Growth factor delivery-base tissue engineering: general approaches and a review of recent developments. J Controll Release 2011; 8: 153-70.
19. Zhao XR. Research on the construction of a 3D liver tumor model and its application on drug sensitivity test. Beijing: Tsinghua University. 2014.
20. Zhao X, Wang X. Preparation of an adipose-derived stem cell/fibrin-poly(d,l-lactic-co-glycolic acid) construct based on a rapid prototyping technique. J Bioact Compat Polym 2013; 28: 191-203.
21. Zhao X, Liu L, Wang J, et al. In vitro vascularization of a combined system based on a 3D printing technique J Tissue Eng Regen Med 2014.doi:10.1002/term.1863.
22. Xu M, Yan Y, Liu H, et al. Control adipose-derived stromal cells differentiation into adipose and endothelial cells in a 3-D structure established by cell-assembly technique. J Bioact Compat Polym 2009; 24: 31-47.
23. Wang X. Spatial effects of stem cell engagement in 3D printing constructs. J Stem Cells Res Rev & Rep 2014; 1; 5-9.
24. Lee KY, Peters MC, Anderson KW, Mooney DJ. Controlled growth factor release from synthetic extracellular matrices. Nature 2000; 408: 998-1000.
25. Ginty PJ, Barry JJA, White LJ, et al.Controlling Protein Release from scaffolds using Polymer Blends and Composites. Eur J Pharm Biopharm 2008; 68: 82-9.
26. Atala A, Kasper FK, Mikos AG. Engineering complex tissues. Sci Transl Med 2012; 4: 160rv12.
27. Wang X. Intelligent freeform manufacturing of complex organs. Artif Organs 2012; 36: 951-61.
28. Wang XH, Yan YN, Zhang RJ. Recent trends and chanllenges in complex organ manufacturing. Tissue Eng Part B. 2010; 16: 189-97.
29. Wang X, Tuomi J, Mäkitie AA, et al. The integrations of biomaterials and rapid prototyping techniques for intelligent manufacturing of complex organs. In: Pignatello R, editor. Advances in Biomaterials Science and Biomedical Applications. Croatia: InTech, 2013, p.437-63.
30. Wang X. Overview on biocompatibilities of implantable biomaterials. In: Pignatello R, editor. Advances in Biomaterials Science and Biomedical Applications. Croatia: InTech; 2013, p. 111-55.
31. Wang X, Yan Y, Zhang R. Gelatin-Based hydrogels for controlled cell assembly. In: Ottenbrite RM, Park K, Okano T, editors. Biomedical Applications of Hydrogels Handbook. New York: Springer, 2010. p. 269-284.
32. Wang X, Zhang Q. Overview on "Chinese-Finnish workshop on biomanufacturing and evaluation techniques". Artif Organs 2011; 35: E191-3.
33. Wang X, Yan Y, Zhang R. Rapid prototyping as a tool for manufacturing bioartificial livers. Trends Biotechnol 2007; 25: 505-13.
34. Petite H, Viateau V, Bensaid W, et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000; 18: 959-63.
35. Nguyen LH, Annabi N, Nikkhah M, et al. Vascularized bone tissue engineering: approaches for potential improvement. Tissue Eng Part B Rev 2009; 15: 363-82.
36. Park YJ, Lee YM, Lee JY, et al. Controlled release of plateletderived growth factor-BB from chondroitin sulfate–chitosan sponge for guided bone regeneration. J Controll Release 2000; 67: 385-94.
37. Yang HS, La WG, Bhang SH, et al. Apatite-coated collagen scaffold for bone morphogenetic protein-2 delivery, Tissue Eng 2011; 17: 1-12.
38. Kimura Y, Miyazaki N, Hayashi N, et al. Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Tissue Eng. Part A 2010; 16: 1263-70.
39. Wu B, Zheng QX, Guo XD, et al. Preparation and ectopic osteogenesis in vivo of scaffold based on mineralized recombinant human-like collagen loaded with synthetic BMP-2-derived peptide. Biomed. Mater 2008; 3: 044111.
40. Bessa PC, Balmayor ER, Azevedo HS, et al. Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release. Tissue Eng. Part C Meth 2010; 16: 937-45.
41. Phillips FM, Turner S, Seim HB, et al. In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model. Spine J 2006; 6: 500-6.
42. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat. Biotechnol 2001; 19: 1029-34.
43. Wang XQ, Esther W, Zhang XH, et al. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Controll Release 2009; 134: 81-90.
44. Vo TN, Kasper FK, Mikos AG. Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliver Rev 2012; 64: 1292-309.
45. Lu HH, Vo JM, Chin HS, et al. Controlled delivery of platelet-rich plasma-derived growth factors for bone formation. J. Biomed. Mater. Res. A 2008; 86: 1128-36.
46. Gallego L, Junquera L, García V, et al. Repair of rat mandibular bone defects by alveolar osteoblasts in a novel plasma-derived albumin scaffold.Tissue Eng. Part A 2010; 16: 1179-87.
47. Bi L, Cheng W, Fan H, Pei G, Reconstruction of goat tibial defects using an injectable tricalcium phosphate/chitosan in combination with autologous platelet-rich plasma. Biomaterials 2010; 31: 3201-11.
48. Holland TA, Mikos AG. Advances in drug delivery for articular cartilage. J Controll Release 2003; 86: 1-14.
49. Wang W, Li B, Yang J, et al. The restoration of full-thickness cartilage defects with BMSCs and TGF-beta 1 loaded PLGA/fibrin gel constructs. Biomaterials 2010; 31: 8964-73.
50. Kim SE, Park JH, Cho YW, et al. Porous chitosan scaffold containing microspheres loaded with transforming growth factor- b1: Implications for cartilage tissue engineering. J Controll Release 2003; 91: 365-74.
51. Spiller KL, Liu Y, Holloway JL, et al. A novel method for the direct fabrication of growth factor-loaded microspheres within porous nondegradable hydrogels: Controlled release for cartilage tissue engineering. J Controll Release 2012; 157: 39-45.
52. Holland TA, Tabata Y, Mikos AG. In vitro release of transforming growth factor-_1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Controll Release 2003; 91: 299-313.
53. Wang XQ, Wenk E, Zhang XH, et al. Growth factor gradients via microsphere delivery in biopolymer scaffold for osteochondral tissue engineering. J Control Release 2009; 134: 81-90.
54. Elisseeff J, Mclntosh W, Fu K, Blunk T, et al. Controlled-release of IGF-I and TGF-P 1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 2001; 19: 1098-104.
55. Hollanda TA, Tabatab Y, Mikos AG. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Controll Release 2005; 101: 111-25.
56. Attanasio S, Snell J. Therapeutic angiogenesis in the management of critical limb ischemia: current concepts and review. Cardiol Rev 2009; 17: 115-20.
57. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 2004; 109: 2692-7.
58. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol 1999; 237: 1-30.
59. Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 2003; 112: 1142-51.
60. Murphy WL, Peters MC, Kohn DH, et al. Sustained release of vascular endothelial growth factor from mineralized poly(lactidecoglycolide) scaffolds for tissue engineering. Biomaterials 2000; 21: 2521-7.
61. Rich MH, Lee MK, Baek K, et al. Material-mediated proangiogenic factor release pattern modulates quality of regenerated blood vessels. J Controll Release 2014; 196: 363-9.
62. Nimni ME. Polypeptide growth factors: targeted delivery systems. Biomaterials 1997; 18: 1201-5.
63. Fabio RF, Beatriz P, Elisa G, et al. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissueremodeling in an acute myocardial ischemia-reperfusion model. J Controll Release 2010; 147: 30-7.
64. Golub JS, Kim YT, Duvall CL, Bellamkonda RV,et al. Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth. Am J Physiol-Heart C 2010; 298: 1959-65.
65. Silva EA, Mooney DJ. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost 2007; 5: 590-8.
66. Tabata Y, Miyao M, Ozeki M, Ikada Y. Controlled release of vascular endothelial growth factor by use of collagen hydrogels. J Biomater Sci Polym Ed 2000; 11: 915-30.
67. Chiua LL, Radisic M. Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials 2011; 32: 1280-90.
68. Gaffney MM, Hynes SO, Barry F, O'Brien T. Cardiovascular gene therapy: current status and therapeutic potential. Br. J. Pharmacol 2007; 152: 175-88.
69. Segers VFM, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008; 451: 937–42.
70. Prabhakaran MP, Venugopal J, Kai D, Ramakrishna S. Biomimetic material strategies for cardiac tissue engineering. Mat Sci Eng C 2011; 31: 503-13.
71. Meier P, Gloekler S, Marchi SF, et al. Myocardial salvage through coronary collateral growth by granulocyte colony-stimulating factor in chronic coronary artery disease: a controlled randomized trial. Circulation 2009; 120: 1355-63.
72. Tang YD, Hasan F, Giordano FJ, et al. Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial. Am. Heart J.2009; 158: 941-7.
73. Takehara N, Tsutsumi Y, Tateishi K, et al. Controlled Delivery of Basic Fibroblast Growth Factor Promotes Human Cardiosphere-Derived Cell Engraftment to Enhance Cardiac Repair for Chronic Myocardial Infarction. J Am Coll Cardiol 2008; 52: 1858-65.
74. Formiga FR, Pelacho B, Garbayo E, et al. Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration. J Controll Release 2014; 173: 132-9.
75. Kim JH, Jung Y, Kim SH, et al. The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides. Biomaterials 2011; 32: 6080-8.
76. Böhm F, Köhler UA, Speicher T, Werner S. Regulation of liver regeneration by growth factors and cytokines. EMBO Mol Med. 2010; 2(8): 294-305.
77. Mooney DJ, Kaufmann PM, Sano K. Localized delivery of epidermal growth factor improve the survival of transplanted hepatocytes. Biotechnol Bioeng 2003; 50: 9214-20.
78. Chen PF, Wei WB, Tan YZ, Hu C. In vitro differentiation of rat bone marrow mesenchymal stem cells into hepatocyte-like cells induced by growth factor. CN J Tissue Eng Res 2012; 49: 422-9.
79. Cao X, Schoichel MS. Dilivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials 1999; 20: 329-39.
80. Wang SG, Cai Q, Lv Z. Research and application of drug controlled release technique in tissue engineering. CN J Repa Reconstructive Surgery 2011; 15: 280-5.